Early Clinical Trial Design Recommendations in Oncology Based on Overall Success across Phases I, II, and III

ASR Stark - 2017 - rave.ohiolink.edu
Conventionally, drug development has spanned three distinct phases, and the success rate
for experimental drugs across phases has been less than 15%(Hay, Thomas, Craighead …

Minimally invasive in tumor multidrug comparative analysis with contrast‐enhanced MRI in mice

WS Kerwin, I Tretyak, MO Grenley… - Magnetic …, 2016 - Wiley Online Library
Purpose To facilitate decision making in the oncology clinic, technologies have recently
been developed to independently inject and assess multiple anticancer agents directly in a …

Cancer immunotherapy: tumor vaccination, IL-12 gene therapy and metronomic chemotherapy

S Denies - 2015 - biblio.ugent.be
The complexity of tumor immunobiology urges for multimodal immunotherapeutic
approaches. Therefore, in this thesis, a combination of tumor vaccination, interleukin-12 (IL …

in Prostate Cancer

O Sartor, B Lewis - Management of Castration Resistant Prostate Cancer - Springer
The alkaline earth metals in the periodic table contain a series of elements including calcium
(Ca), strontium (Sr), barium (Ba), and radium (Ra)(see Fig. 11.1). Each of these compounds …

Radium-223 and Other Radiopharmaceuticals in Prostate Cancer

O Sartor, B Lewis - Management of Castration Resistant Prostate Cancer, 2014 - Springer
Prostate cancer is a bone-metastatic disease but until recently bone-targeted therapies had
never demonstrated improvements in survival. Prior radiopharmaceuticals have …

Bayesian Adaptive Methods for Clinical Trials of Targeted Agents

P Thall - Design and Analysis of Clinical Trials for Predictive …, 2015 - api.taylorfrancis.com
This chapter provides an overview of Bayesian concepts and methods for design and
conduct of clinical trials of treatment regimens, including targeted agents. A targeted …

[PDF][PDF] The Oncologist® Endocrinology

JC YAO, DR LAGUNES, MH KULKE - Citeseer
In the past 3 years, we have witnessed the completion of four randomized phase III studies
in neuroendocrine tumors and the approval of two new drugs, everolimus and sunitinib, for …

[图书][B] Is an intermediate dose of LMWH effective for secondary prevention of recurrent venous thromboembolism in pregnant patients diagnosed with deep vein …

E Gándara - 2012 - search.proquest.com
Statement of the problem:-The primary objective of this thesis was to determine the best
study design to evaluate the safety and effectiveness of an intermediate dose of low …

[PDF][PDF] Verpflichtung und Verantwortung der Onkologie zur Kostenkontrolle

G der Kassenärztlichen Vereinigungen KVen - Onkologie, 2012 - scholar.archive.org
Sie zeigen Zweierlei: 1. Dezentralisierung ist nachteilig, einzelne Alleskönner sind teuer,
wirtschaftlich ineffizient. Spezifizierung und ein gewisses Maß an Zentralisierung sind …

[PDF][PDF] Mitteilungen onkologischer Gesellschaften· Reports of Oncological Societies

S Geiger, HJ Stemmler, P Suhl, P Stieber… - Oncology Research …, 2012 - karger.com
Sie zeigen Zweierlei: 1. Dezentralisierung ist nachteilig, einzelne Alleskönner sind teuer,
wirtschaftlich ineffizient. Spezifizierung und ein gewisses Maß an Zentralisierung sind …